financetom
Business
financetom
/
Business
/
Franklin BSP Realty Trust Q1 Distributable Earnings Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Franklin BSP Realty Trust Q1 Distributable Earnings Decline
Apr 29, 2024 3:02 PM

05:30 PM EDT, 04/29/2024 (MT Newswires) -- Franklin BSP Realty Trust ( FBRT ) reported Q1 distributable earnings Monday of $0.41 per diluted share, down from $0.44 a year earlier.

Analysts polled by Capital IQ expected $0.39.

Shares of the company rose 2% in after-market trading.

Price: 12.95, Change: +0.25, Percent Change: +1.97

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Accenture Gets $190 Million US Department of State Contract
Accenture Gets $190 Million US Department of State Contract
Sep 16, 2024
10:26 AM EDT, 09/16/2024 (MT Newswires) -- Accenture ( ACN ) unit Accenture Federal Services said Monday it has won a $190 million contract from the US Department of State. Under the contract, Accenture Federal Services will provide data and systems engineering backing for the US President's Emergency Plan for AIDS Relief, the company said. The contract has a base...
Cullinan Therapeutics Submits Investigational New Drug Application to Treat Systemic Lupus Erythematosus
Cullinan Therapeutics Submits Investigational New Drug Application to Treat Systemic Lupus Erythematosus
Sep 16, 2024
10:25 AM EDT, 09/16/2024 (MT Newswires) -- Cullinan Therapeutics ( CGEM ) said Monday it filed an investigational new drug application to the US Food and Drug Administration to evaluate its CLN-978 to treat systemic lupus erythematosus, a chronic autoimmune disorder. CLN-978 is a half-life extended CD19xCD3 bispecific T cell engager construct, the company said. Price: 18.02, Change: +0.07, Percent...
BRIEF-U.S. SEC Says Ordered That F-1 IPO Filing Filed By Jiufuyuan Biotechnology Co Ltd Be Declared Abandoned On Sept 16
BRIEF-U.S. SEC Says Ordered That F-1 IPO Filing Filed By Jiufuyuan Biotechnology Co Ltd Be Declared Abandoned On Sept 16
Sep 16, 2024
Sept 16 (Reuters) - * U.S. SEC SAYS ORDERED THAT F-1 IPO FILING FILED BY JIUFUYUAN BIOTECHNOLOGY CO LTD BE DECLARED ABANDONED ON SEPT 16- SEC FILING * U.S. SEC SAYS JIUFUYUAN BIOTECHNOLOGY CO LTD WHICH HAD FILED FOR US IPO IN NOV 2023 FAILED TO RESPOND TO SEC'S NOTICE UNDER RULE 479 Source text - https://bityl.co/S30X Further company coverage:...
Market Chatter: Carlyle Reportedly Rekindles Plans for Nouryon IPO
Market Chatter: Carlyle Reportedly Rekindles Plans for Nouryon IPO
Sep 16, 2024
02:44 PM EDT, 09/16/2024 (MT Newswires) -- Carlyle Group ( CG ) is once again considering plans to take Nouryon public and has hired investment banks, including Barclays ( JJCTF ) and Goldman Sachs ( GS ) , for help with the IPO, Bloomberg reported Monday citing people familiar with the matter. The company is looking to take the business...
Copyright 2023-2026 - www.financetom.com All Rights Reserved